New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
18:41 EDTMELI, ZNGA, POST, CPST, TKMR, LULU, MNST, SCTY, NVDA, MDVN, ANET, UBNT, LRAD, FOLD, SLXPOn The Fly: After Hours Movers
UP AFTER EARNINGS: MercadoLibre (MELI), up 14.2%... Amicus Therapeutics (FOLD), up 10.5%... LRAD Corporation (LRAD), up 18%... Ubiquiti Networks (UBNT), up 7%... Arista Networks (ANET), up 8.8%... Medivation (MDVN), up 4.2%... NVIDIA (NVDA), up 4.5%... SolarCity (SCTY), up 4.6%... Monster Beverage (MNST), up 2.5%. ALSO HIGHER: Lululemon Athletica (LULU), up 5.7% following announcement that founder Chip Wilson will sell half his stake to Advent International... Tekmira Pharmaceuticals (TKMR), up 7.2% after announcing that the FDA verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola to a partial clinical hold. DOWN AFTER EARNINGS: Capstone Turbine (CPST), down 12%... Post Holdings (POST), down 13.1% after reporting quarterly results and that it acquired American Blanching for $128M in cash... Zynga (ZNGA), down 7.2% after lowering fiscal 2014 guidance... Salix Pharmaceuticals (SLXP), down 3.4%.
News For MELI;FOLD;LRAD;UBNT;ANET;MDVN;NVDA;SCTY;MNST;LULU;TKMR;CPST;POST;ZNGA;SLXP From The Last 14 Days
Check below for free stories on MELI;FOLD;LRAD;UBNT;ANET;MDVN;NVDA;SCTY;MNST;LULU;TKMR;CPST;POST;ZNGA;SLXP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 22, 2014
08:09 EDTSLXPPar Pharmaceutical in settlement deal with Salix
Subscribe for More Information
07:14 EDTNVDAGSM Association to hold a conference
Subscribe for More Information
06:33 EDTMNSTMonster Beverage price target raised to $110 from $94 at Stifel
Subscribe for More Information
September 19, 2014
16:14 EDTPOSTGabelli reports 5.29% stake in Post Holdings
Subscribe for More Information
07:54 EDTSLXPSalix price target raised to $192 from $161 at Canaccord
Subscribe for More Information
07:40 EDTLULUVF Corp. upgraded to Buy, could target lululemon, says KeyBanc
As previously reported, KeyBanc upgraded VF Corp (VFC) to Buy from Hold with an $80 price target. The firm cited momentum at its Timberland brand, VF's strong brand portfolio, and the potential for another large M&A transaction. The analyst said VF Corp. is well positioned to complete another large deal and could target lululemon (LULU). KeyBanc believes lululemon's quality issues, forecasting and store operational challenges play into VF Corp.'s strengths and that such an acquisition would be 10c accretive initially and 80c accretive over time.
September 18, 2014
13:44 EDTSLXPSalix announces FDA sNDA resubmission for XIFAXAN complete
Subscribe for More Information
13:03 EDTZNGATwo top game develoeprs leave Zynga, VentureBeat says
Subscribe for More Information
10:00 EDTMDVNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:35 EDTCPSTCapstone Turbine announces 2 MW order for offshore platform
Capstone Turbine announced that it received an order for two C1000 microturbines for an offshore oil and gas platform in Africa. The two C1000s will run on flare gas to power artificial lift equipment, more specifically electrical submersible pumps that are used to increase oil production. The artificial lift market was more than $9.2B in 2012 and is forecasted to grow to $16B in 2018. Africa and the Middle East are expected to represent 13% of this growth year over year.
07:47 EDTMDVNMedivation upgraded to Buy at Canaccord
As reported previously, Canaccord upgraded Medivation to Buy from Hold citing the pre-chemotherapy opportunity and meaningful incremental share gains of its Xtandi drug. Canaccord raised its price target on Medivation to $132 from $60.
07:31 EDTSLXPSalix secures additional intellectual property relating to Rifaximin
Salix Pharmaceuticals announced that Cipla granted Salix exclusive rights under certain patent applications in the “Rifaximin Complexes” patent family controlled by Cipla. The grant is on a worldwide basis, excluding the countries of Asia and Africa. Additionally, Salix and Cipla have expanded the scope of their 2009 exclusive license agreement whereby Cipla granted Salix exclusive rights in the U.S., Canada and Mexico under certain patent rights covering amorphous rifaximin. By means of this amendment to the 2009 agreement, the rights already licensed to Salix in the U.S., Canada and Mexico are expanded to include certain patent rights in the European Union, Japan, Australia, New Zealand and South Korea. Salix is required to make an up-front payment and, upon achievement, additional regulatory milestone payments to Cipla in respect of the new license agreement regarding the “Rifaximin Complexes” patent rights. Salix also will pay royalties on net sales of products covered by the “Rifaximin Complexes” patents licensed to Salix
06:13 EDTMDVNMedivation upgraded to Buy from Hold at Canaccord
Subscribe for More Information
September 17, 2014
15:02 EDTTKMRCongressman questions why FDA hasn't moved on Ebola drug, The Hill says
Republican Congressman Michael Burgess said he was "bewildered" as to why the FDA continues to have a hold on Tekmira's TKS-Ebloa drug, a treatment for Ebola, according to The Hill. However, Democratic Congresswoman Betty McCollum warned against using Africa as a "testing ground" for drugs that haven't been property screened, the website noted. Reference Link
11:11 EDTPOSTGeneral Mills crumbles after earnings miss, downgrade
Subscribe for More Information
11:02 EDTLULUOptions with decreasing implied volatility
Subscribe for More Information
08:02 EDTSLXPSalix M&A chatter warranted, says Canaccord
Subscribe for More Information
September 16, 2014
11:56 EDTSCTYStocks with call strike movement; PBR SCTY
Petrobras (PBR) January 20 call option implied volatility increased 2% to 54, SolarCity (SCTY) January 80 call option implied volatility increased 3% to 53 according to IVolatility.
10:37 EDTLULUOptions with decreasing implied volatility
Subscribe for More Information
09:59 EDTMNSTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ACI Worldwide (ACIW) initiated with a Neutral at Sterne Agee... ADP (ADP) initiated with a Market Perform at Bernstein... ANSYS (ANSS) initiated with a Sector Perform at RBC Capital... Accenture (ACN) initiated with a Market Perform at Bernstein... Blackhawk (HAWK) initiated with a Neutral at Sterne Agee... Coca-Cola (KO) initiated with a Market Perform at Cowen... Cognizant (CTSH) initiated with an Outperform at Bernstein... Constellation Brands (STZ) initiated with a Market Perform at Cowen... Dr Pepper Snapple (DPS) initiated with a Market Perform at Cowen... GenCorp (GY) initiated with a Hold at KeyBanc... Global Payments (GPN) initiated with a Neutral at Piper Jaffray... GoPro (GPRO) initiated with a Buy at Cleveland Research... Green Dot (GDOT) initiated with a Neutral at Sterne Agee... Lionsgate (LGF) initiated with a Buy at ISI Group... MEDNAX (MD) initiated with a Neutral at SunTrust... MasterCard (MA) initiated with a Buy at Sterne Agee... Molson Coors (TAP) initiated with an Outperform at Cowen... Monster Beverage (MNST) initiated with a Market Perform at Cowen... NetSuite (N) initiated with an Outperform at RBC Capital... Oracle (ORCL) assumed with a Sector Perform at RBC Capital... PepsiCo (PEP) initiated with an Outperform at Cowen... SAP (SAP) initiated with a Sector Perform at RBC Capital... Teekay (TK) initiated with a Hold at Deutsche Bank... Tesla (TSLA) initiated with a Buy at ISI Group... Visa (V) initiated with a Buy at Sterne Agee... Western Union (WU) initiated with a Neutral at Sterne Agee... Workday (WDAY) initiated with an Outperform at RBC Capital... Yelp (YELP) initiated with a Neutral at RW Baird... Zillow (Z) initiated with an Overweight at Stephens... zulily (ZU) initiated with an Outperform at RW Baird.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use